Abstract: The present invention relates to a recombinant adenovirus with increased in-vivo safety, tissue specificity, and anticancer activities, and a use thereof. Specifically, the recombinant adenovirus comprising: a promoter of the liver tissue-specific phosphoenolpyruvate carboxykinase (PEPCK) gene; a trans-splicing ribozyme which is operably linked to the promoter and acts on a cancer-specific gene; a therapeutic gene or a reporter gene which is linked to the 3? exon of the ribozyme; and a serotype 35 fiber knob and a serotype 5 shaft, in which the orf4 gene is deleted from adenovirus E1, E3 and E4 orf1, shows remarkable in-vivo safety, high specificity for a target tissue, and remarkable anticancer effects, and thus can be useful for an anticancer drug or a cancer diagnostic agent as a gene delivery vector.

Abstract: An electrolyte for a rechargeable lithium battery includes a non-aqueous organic solvent; a lithium salt; a first compound represented by Chemical Formula 1; and a second compound represented by Chemical Formula 2, wherein an amount of the first compound is about 0.05 wt % to about 10 wt % and an amount of the second compound is about 0.05 wt % to about 10 wt %. In Chemical Formulae 1 and 2, the substituents are the same as defined in the detailed description.

Abstract: A thin-film ceramic capacitor includes: a body in which a plurality of dielectric layers and first and second electrode layers are alternately disposed on a substrate; and first and second electrode pads disposed on an external surface of the body. The dielectric layer contains a mixed phase of a perovskite phase having ferroelectric properties and a pyrochlore phase having paraelectric properties, the pyrochlore phase being disposed on interfaces between the dielectric layers and the first and second electrode layers in lower portions of the dielectric layers.

Abstract: A display including an electrowetting prism array is provided. The display includes: a light source, a 2-dimensional (2D) display for providing an image using light from the light source, a prism array in which a refractive power of one or more prisms of the prism array is adjustable in real time, and an optical element which increases a refraction of light transmitted therethrough. In the display, the optical element may be disposed in front of or behind the prism array. The optical element may be a convex lens, a Fresnel lens, a holographic optical element (HOE), a diffraction optical element (DOE), or a second electrowetting prism array. The convex lens may be a variable focus lens.

Abstract: A thin film capacitor includes a body including alternately stacked first and second electrode layers and dielectric layers on a substrate, the second electrode layer including a second lower electrode layer and a second upper electrode layer formed on the second lower electrode layer, the second lower electrode layer including a material having a higher band gap energy than the first electrode layer and the second upper electrode layer.

Abstract: A thin-film ceramic capacitor includes: a body in which a plurality of dielectric layers and first and second electrode layers are alternately disposed on a substrate; and first and second electrode pads disposed on an external surface of the body. The dielectric layer contains a mixed phase of a perovskite phase having ferroelectric properties and a pyrochlore phase having paraelectric properties, the pyrochlore phase being disposed on interfaces between the dielectric layers and the first and second electrode layers in lower portions of the dielectric layers.

Abstract: Disclosed are an electrolyte for a rechargeable lithium battery including a lithium salt, organic solvent and an additive including a compound represented by the following Chemical Formula 1 and a rechargeable lithium battery including the same. In the above Chemical Formula 1, R is the same as described in the detailed description.

Abstract: An electrolyte for a rechargeable lithium battery includes a lithium salt, a non-aqueous organic solvent, and an additive. The additive is represented by Chemical Formula 1, and is included in an amount of about 0.05 wt % to about 3 wt % based on the total amount of the electrolyte. A rechargeable lithium battery including the same is also disclosed. Chemical Formula 1 is as described in the present specification.

Abstract: Disclosed are an electrolyte for a rechargeable lithium battery including a lithium salt, a non-aqueous organic solvent, and an additive represented by the following Chemical Formula 1, and a rechargeable lithium battery including the same. Definition of Chemical Formula 1 is the same as described in the detailed description.

Abstract: Disclosed is a rechargeable lithium battery including a positive electrode; a negative electrode including a negative active material, the negative active material including a silicon-based material; and an electrolyte solution including a lithium salt, a non-aqueous organic solvent, and an additive. The additive includes an ethylene carbonate-based compound represented by Chemical Formula 1 and a pyridine-based compound represented by Chemical Formula 2: R11, R12 and R1 to R5 are each independently hydrogen, a halogen, a substituted or unsubstituted C1 to C20 alkyl group, or a C1 to C20 haloalkyl group; at least one of R11 and R12 is a halogen; and at least one of R1 to R5 is a halogen.

Abstract: A rechargeable lithium battery includes a compound represented by Chemical Formula 1: In Chemical Formula 1, each of k, l, and m is independently an integer of 0 to 20, n is an integer of 1 to 7, and k, l and m are selected such that the compound of Chemical Formula 1 has an asymmetrical structure. The compound of Chemical Formula 1 may be included in the positive electrode, the negative electrode, or the electrolyte of the rechargeable lithium battery.

Abstract: A health functional food composition and a pharmaceutical composition for preventing or ameliorating a non-alcoholic fatty liver disease include an extract of Dolichos lablab Linne as an active ingredient. The extract of Dolichos lablab Linne, being an active ingredient, effectively reduces accumulation of triglyceride in hepatocarcinoma cell line (HepG2). Therefore, the compositions are used for functional foods and medicines for the prevention or amelioration of non-alcoholic fatty liver.

Abstract: Provided is a micro-lens capable of changing a focal length. The micro-lens includes a plurality of electrodes, and an electrowetting liquid layer that is separable from the electrodes and that has a focal length that is controlled by a voltage applied to the electrodes.

Abstract: An electrolyte for a rechargeable lithium battery includes an organic solvent including C3 to C5 alkyl propionate, and the electrolyte further includes a lithium salt and a compound represented by Chemical Formula 1, wherein, in Chemical Formula 1, k, l, and m are independently integers of 0 to 20, k, l, and m are selected, so that Chemical Formula 1 has an asymmetric structure, n is an integer of 1 to 7, and R1, R2, R3, R4, R5, and R6 are independently hydrogen, an alkyl group, an alkoxy group, or a fluoroalkyl group.

Abstract: Provided is a technology for controlling an electrowetting cell. The electrowetting cell may be controlled by applying a preset first voltage to the electrowetting cell, measuring a first circuit parameter between any one side surface and a conductive liquid disposed in the electrowetting cell and determining whether a reset second voltage is to be applied to the electrowetting cell based on the measured first circuit parameter.

Abstract: An electrolyte for a rechargeable lithium battery and a rechargeable lithium battery, the electrolyte including a lithium salt, a non-aqueous organic solvent, and an additive represented by the following Chemical Formula 1: wherein, in Chemical Formula 1, R1 to R3 are each independently a substituted or unsubstituted C1 to C10 alkylene group, a substituted or unsubstituted C3 to C30 cycloalkylene group, a substituted or unsubstituted C6 to C30 arylene group, or a substituted or unsubstituted C2 to C30 heteroarylene group.

Abstract: An electrolyte for a rechargeable lithium battery includes a non-aqueous organic solvent; a lithium salt; a first compound represented by Chemical Formula 1; and a second compound represented by Chemical Formula 2, wherein an amount of the first compound is about 0.05 wt % to about 10 wt % and an amount of the second compound is about 0.05 wt % to about 10 wt %. In Chemical Formulae 1 and 2, the substituents are the same as defined in the detailed description.

Abstract: Disclosed is a Madin-Darby canine kidney (MDCK)-derived cell line. The MDCK-derived cell line is derived from MDCK cells deposited under accession number ATCC CCL-34. The MDCK-derived cell line can be prepared by serum-free culture and suspension culture. Preferably, the MDCK-derived cell line has low or no tumorigenicity. The MDCK-derived cell line is preferably selected from MDCK Sky1023, MDCK Sky10234 and MDCK Sky3851. Further disclosed are a culture method for growing the MDCK-derived cells and a method for producing a vaccine virus using the MDCK-derived cells.

Abstract: Provided are an integral imaging type 3-dimensional (3D) image display apparatus and a 3D image pickup apparatus for increasing a depth by using an electrowetting lens array. The 3D image display apparatus includes a display panel and an electrowetting lens array having an electrically adjustable variable focal distance. The 3D image display apparatus displays a plurality of images having different depths on different focal planes and thus a depth of a 3D image by using one display panel.

Abstract: Systems, methods, and articles of manufacture to determine connectivity are disclosed. An example method includes identifying a radio network controller serving a NodeB, identifying a first connection between the NodeB and an integrated access device, identifying a virtual circuit communicatively coupling the integrated access device and a mobile service node, identifying a second connection between the integrated access device and network termination equipment, identifying a third connection between the network termination equipment and an Ethernet aggregation node, identifying, with the processor, that a pathway between the radio network controller and the NodeB includes the first, second, and third connections, and storing the pathway between the radio network controller and the NodeB.